Skip to main content

Advertisement

Log in

Does vitamin A prevent high-dose-methotrexate-induced D-xylose malabsorption in children with cancer?

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

Our aim was to explore whether vitamin A has protective effect on high-dose-methotrexate (HDMTX)-induced intestinal D-xylose malabsorption in children with leukemia and lymphoma.

Patients and methods

We performed a prospective randomized unblinded study of vitamin A in 35 children with leukemia and lymphoma who were planned to receive HDMTX 3 g/m2 and 5 g/m2, respectively. Twenty-two patients (group 1) received a single dose of 180,000 IU a day before HDMTX was given, and 13 (group 2) received only HDMTX. The vitamin A group received the vitamin only once. Oral D-xylose absorption tests before and 7 days after HDMTX were carried out to evaluate intestinal absorption. Retinol-binding protein (RBP) levels prior to therapy were also measured for vitamin A status.

Results

Although we observed no difference of HDMTX-induced toxicity, including hematological, dermatological, systemic, and other toxicities, between groups, the D-xylose absorption test was significantly better in-group 1 (p=0.030). Absorption was decreased in five of 22 patients (23%) who received vitamin A comparing to eight of 13 (62%) who received only HDMTX (p=0.033). RBP levels were lower than normal in 13 of 22 patients in-group 1 and nine of 13 in group 2. In patients whose RBP levels were lower than normal, HDMTX-induced toxicity was lower in the group 1 than group 2 but not statistically significant. No sign of vitamin A toxicity was observed throughout the study.

Conclusion

The administration of vitamin A before HDMTX may protect against drug-induced D-xylose malabsorption in children with cancer. Further studies are apparently needed to clarify the full benefits of vitamin A in preventing HDMTX-induced mucosal damage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Almekinder J, Manda W, Soko D, Lan Y, Hoover DR, Semba RD (2000) Evaluation of plasma retinol-binding protein as a surrogate measure for plasma retinol concentrations. Scand J Clin Lab Invest 60:199–203

    Article  CAS  PubMed  Google Scholar 

  2. Balis FM, Holcenberg JS, Poplack DG (1997) General principles of chemotherapy. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology, 3rd edn, Lippincot, Philadelphia, pp 215–272

  3. Barclay AJ, Foster A, Sommer A (1987) Vitamin A supplements and mortality related to measles: a randomized clinical trial. BMJ 294(6567): 294–296

    CAS  PubMed  Google Scholar 

  4. Bernard A, Dandrifosse G, Romain N, Forget P (1989) Effect on the intestinal mucosa of PGE2-treated rats. Life Sciences 45:2591–2603

    Article  CAS  PubMed  Google Scholar 

  5. Craig R, Atkinson A (1988) D-xylose testing: A review. Gastroenterology 95:223–231

    CAS  PubMed  Google Scholar 

  6. DeLap R (1996) Antimetabolic agents. In: Kirkwood J, Lotze M, Yasko J (eds) Current cancer therapeutics, 2nd edn, Current Medicina, Philadelphia, pp 50–62

  7. Eledrisi SM, Mc Kinney K Vitamin A toxicity. http://www.emedicine.com/med/topic2382.htm.

  8. Hasan M and Finucane P (1993) Intestinal malabsorption presenting with night blindness. Br J Clin Pract 47:275–276

    CAS  PubMed  Google Scholar 

  9. Hatun S, Tezic T (1995) Vitamin A status of healthy infants in Ankara, Turkey. Turkish Journal of Pediatrics 37:187–192

    CAS  PubMed  Google Scholar 

  10. Hatun S, Tezic T, Kunak B, Cengiz AB (1995) Vitamin A levels of children with measles in Ankara, Turkey. Turk JPediatr 37:193–200

    CAS  Google Scholar 

  11. Hussey GD, Klein M (1990) A randomized, controlled trial of vitamin A in children with severe measles. N Engl J Med 323:160–164

    CAS  PubMed  Google Scholar 

  12. Koninkx JF, Stemerdink AF, Mirck MH, Egberts HJ, van Dijk JE, Mauwen JM (1988) Histochemical changes in the composition of mucins in goblet cells during methotrexate-induced mucosal atrophy in rats. Exp Pathol 34:125–133

    CAS  PubMed  Google Scholar 

  13. Kosakai Y, Horie T, Awazu S (1991) Protective effect of vitamin A against the methotrexate-induced damage to small intestine: A study on the crypt cells. Pharmacol Toxicol 69:291–295

    CAS  PubMed  Google Scholar 

  14. Maldonado Y (2000) Measles. In: Nelson WE, Behrman RE, Kliegman RM, Jenson HB (eds) Textbook of pediatrics, 16th ed, Saunders, Philadelphia, pp 946–950

  15. Nagai Y, Horie T, Awazu S (1993) Vitamin A, a useful biochemical modulator capable of preventing intestinal damage during methotrexate treatment. Pharmacol Toxicol 73:69–74

    CAS  PubMed  Google Scholar 

  16. National Cancer Institute (1999) Cancer therapy evaluation program, common toxicity criteria, version 2.0

  17. Ottery FD (1994) Rethinking nutritional support of the cancer patient: the new of nutritional oncology. Semin Oncol 21:770–778

    Google Scholar 

  18. Pearson AD, Craft AW, Pledger JV et al. (1984) Small bowel function in acute lymphoblastic leukemia. Arch Dis Child 59:460–465

    CAS  PubMed  Google Scholar 

  19. Quilitz R (1995) Modulation of chemotherapy-induced mucositis. Cancer Control 2:452–459

    PubMed  Google Scholar 

  20. Sibulesky L, Hayes KC, Pronczuk A, Weigel-DiFranco C, Rosner B, Berson EL (1999) Safety of <7500RE (25000 IU) vitamin A daily in adults with retinitis pigmentosa. Am J Clin Nutr 69:656–663

    CAS  PubMed  Google Scholar 

  21. Takeuchi H, Kosakai Y, Tsurui K, Hasegawa K, Horie T, Awazu S (1989) Change in small intestine brush border membranes of rats following methotrexate administration. Pharmacol Toxicol 65:269–273

    CAS  PubMed  Google Scholar 

  22. Thatcher N, Blackledge G, Crowther D (1980) Advanced recurrent squamous cell carcinoma of the head and neck. Result of chemotherapeutic regimen with adriamycin, bleomycin, 5-fluorouracil, methotrexate and vitamin A. Cancer 46:1324–1328

    CAS  PubMed  Google Scholar 

  23. Tsurui K, Kosakai Y, Horie T, Awazu S. (1990) Vitamin A protects small intestine from methotrexate-induced damage in rats. The J Pharmacol Exp Ther 253:1278–1284

    CAS  Google Scholar 

  24. Warden R, Noltrop RS, Francis JL et al (1997) Vitamin A deficiency exacerbates methotrexate-induced jejunal injury in rats. J Nutr 127:770–776

    CAS  PubMed  Google Scholar 

  25. Yamamoto J, Nagai Y, Horie T, Awazu S (1993) Effect of vitamin A on methotrexate cytotoxicity in L1210 murine leukemia cells in culture. Cancer Chemother Pharmacol 32:263–267

    CAS  PubMed  Google Scholar 

  26. Yamamoto J, Horie T, Awazu S (1997) Amelioration of methotrexate-induced malabsorption by vitamin A. Cancer Chemother Pharmacol 39:239–244

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgement

We thank Prof. Dr. Yuksel Bek and Prof. Dr. Murat Erturk from the Departments of Biostatistics and Microbiology of the Medical Faculty of Ondokuz Mayis University for their valuable contribution for revision of the paper.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ayhan Dagdemir.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dagdemir, A., Yildirim, H., Aliyazicioglu, Y. et al. Does vitamin A prevent high-dose-methotrexate-induced D-xylose malabsorption in children with cancer?. Support Care Cancer 12, 263–267 (2004). https://doi.org/10.1007/s00520-004-0591-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-004-0591-8

Keywords

Navigation